AIM IMMUNOTECH INC. (AIM)
AIM ImmunoTech Regains NYSE American Compliance, Company Resolves Stockholder Equity Deficiency
AIM ImmunoTech Regains NYSE American Compliance, Company Resolves Stockholder Equity Deficiency
CoyaTherapeutics - Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease
Humacyte's Bioengineered Blood Vessel Outperforms the Standard of Care for Women on Dialysis in Phase 3 Results Presented at the Society for Vascular Surgery Vascular Annual Meeting
Chaince Digital Announces Launch of USDC Yield Vault on Morpho Curated by AlphaPing
Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
MSCI Publishes Investor Presentation
Rectitude Holdings Ltd Secures Additional AIMS System Orders for Major Infrastructure and Residential Projects Across Singapore
ELECTRA AI to Participate in ROTHs 16th Annual London Conference, June 16-18, 2026
Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease
The Radoff-JEC Group Highlights Seer Inc.’s and Chairman and CEO Omid Farokhzad, M.D.’s History of Value Destruction